While next-generation sequencing has revolutionized the way genomes are sequenced, this technology possesses a fundamental weakness—the inability to easily target specific regions of a genome. To address this, Agilent has developed the SureSelect platform that allows next-generation sequencing researchers to focus their sequencing efforts on genomic targets of interest, greatly improving next-generation sequencing process efficiencies. The SureSelect platform of products allows next-generation sequencing researchers to increase study sample size and reduce overall experimental cost.
More...